Cargando…

Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico

BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Ruiz, Eleazar, Alvarado-Ibarra, Martha, Juan Lien-Chang, Lourdes Esthela, Banda-Garcia, Luisa, Aquino-Salgado, Jorge Luis, Barragan-Ibanez, Gabriel, Ramirez-Romero, Eva Fabiola, Nolasco-Cancino, Cesar, Herrera-Olivares, Wilfrido, Morales-Adrian, Javier de Jesus, Paredes-Lozano, Eugenia Patricia, Espitia-Rios, Maria Eugenia, Gonzalez Lopez-Elizalde, Maria de Monserrat, Lopez-Arroyo, Jose Luis, Trejo-Gomora, Jorge Enrique, De la Pena-Celaya, Jose Antonio, Alvarez-Vera, Jose Luis, Arana-Luna, Luara Luz, Martinez-Rios, Annel, Resendiz-Olea, Rodrigo, Rodriguez-Velasquez, Lucero Jazmin, Zapata-Canto, Nidia, Perez-Zuniga, Juan Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935617/
https://www.ncbi.nlm.nih.gov/pubmed/33738003
http://dx.doi.org/10.14740/wjon1351
_version_ 1783661037207158784
author Hernandez-Ruiz, Eleazar
Alvarado-Ibarra, Martha
Juan Lien-Chang, Lourdes Esthela
Banda-Garcia, Luisa
Aquino-Salgado, Jorge Luis
Barragan-Ibanez, Gabriel
Ramirez-Romero, Eva Fabiola
Nolasco-Cancino, Cesar
Herrera-Olivares, Wilfrido
Morales-Adrian, Javier de Jesus
Paredes-Lozano, Eugenia Patricia
Espitia-Rios, Maria Eugenia
Gonzalez Lopez-Elizalde, Maria de Monserrat
Lopez-Arroyo, Jose Luis
Trejo-Gomora, Jorge Enrique
De la Pena-Celaya, Jose Antonio
Alvarez-Vera, Jose Luis
Arana-Luna, Luara Luz
Martinez-Rios, Annel
Resendiz-Olea, Rodrigo
Rodriguez-Velasquez, Lucero Jazmin
Zapata-Canto, Nidia
Perez-Zuniga, Juan Manuel
author_facet Hernandez-Ruiz, Eleazar
Alvarado-Ibarra, Martha
Juan Lien-Chang, Lourdes Esthela
Banda-Garcia, Luisa
Aquino-Salgado, Jorge Luis
Barragan-Ibanez, Gabriel
Ramirez-Romero, Eva Fabiola
Nolasco-Cancino, Cesar
Herrera-Olivares, Wilfrido
Morales-Adrian, Javier de Jesus
Paredes-Lozano, Eugenia Patricia
Espitia-Rios, Maria Eugenia
Gonzalez Lopez-Elizalde, Maria de Monserrat
Lopez-Arroyo, Jose Luis
Trejo-Gomora, Jorge Enrique
De la Pena-Celaya, Jose Antonio
Alvarez-Vera, Jose Luis
Arana-Luna, Luara Luz
Martinez-Rios, Annel
Resendiz-Olea, Rodrigo
Rodriguez-Velasquez, Lucero Jazmin
Zapata-Canto, Nidia
Perez-Zuniga, Juan Manuel
author_sort Hernandez-Ruiz, Eleazar
collection PubMed
description BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. METHODS: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: ≥ 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. RESULTS: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. CONCLUSIONS: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype.
format Online
Article
Text
id pubmed-7935617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-79356172021-03-17 Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico Hernandez-Ruiz, Eleazar Alvarado-Ibarra, Martha Juan Lien-Chang, Lourdes Esthela Banda-Garcia, Luisa Aquino-Salgado, Jorge Luis Barragan-Ibanez, Gabriel Ramirez-Romero, Eva Fabiola Nolasco-Cancino, Cesar Herrera-Olivares, Wilfrido Morales-Adrian, Javier de Jesus Paredes-Lozano, Eugenia Patricia Espitia-Rios, Maria Eugenia Gonzalez Lopez-Elizalde, Maria de Monserrat Lopez-Arroyo, Jose Luis Trejo-Gomora, Jorge Enrique De la Pena-Celaya, Jose Antonio Alvarez-Vera, Jose Luis Arana-Luna, Luara Luz Martinez-Rios, Annel Resendiz-Olea, Rodrigo Rodriguez-Velasquez, Lucero Jazmin Zapata-Canto, Nidia Perez-Zuniga, Juan Manuel World J Oncol Original Article BACKGROUND: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. METHODS: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: ≥ 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. RESULTS: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. CONCLUSIONS: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype. Elmer Press 2021-02 2021-02-24 /pmc/articles/PMC7935617/ /pubmed/33738003 http://dx.doi.org/10.14740/wjon1351 Text en Copyright 2021, Hernandez-Ruiz et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hernandez-Ruiz, Eleazar
Alvarado-Ibarra, Martha
Juan Lien-Chang, Lourdes Esthela
Banda-Garcia, Luisa
Aquino-Salgado, Jorge Luis
Barragan-Ibanez, Gabriel
Ramirez-Romero, Eva Fabiola
Nolasco-Cancino, Cesar
Herrera-Olivares, Wilfrido
Morales-Adrian, Javier de Jesus
Paredes-Lozano, Eugenia Patricia
Espitia-Rios, Maria Eugenia
Gonzalez Lopez-Elizalde, Maria de Monserrat
Lopez-Arroyo, Jose Luis
Trejo-Gomora, Jorge Enrique
De la Pena-Celaya, Jose Antonio
Alvarez-Vera, Jose Luis
Arana-Luna, Luara Luz
Martinez-Rios, Annel
Resendiz-Olea, Rodrigo
Rodriguez-Velasquez, Lucero Jazmin
Zapata-Canto, Nidia
Perez-Zuniga, Juan Manuel
Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title_full Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title_fullStr Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title_full_unstemmed Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title_short Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
title_sort epidemiology and clinical characteristics of non-hodgkin lymphoma in mexico
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935617/
https://www.ncbi.nlm.nih.gov/pubmed/33738003
http://dx.doi.org/10.14740/wjon1351
work_keys_str_mv AT hernandezruizeleazar epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT alvaradoibarramartha epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT juanlienchanglourdesesthela epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT bandagarcialuisa epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT aquinosalgadojorgeluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT barraganibanezgabriel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT ramirezromeroevafabiola epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT nolascocancinocesar epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT herreraolivareswilfrido epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT moralesadrianjavierdejesus epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT paredeslozanoeugeniapatricia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT espitiariosmariaeugenia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT gonzalezlopezelizaldemariademonserrat epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT lopezarroyojoseluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT trejogomorajorgeenrique epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT delapenacelayajoseantonio epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT alvarezverajoseluis epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT aranalunaluaraluz epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT martinezriosannel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT resendizolearodrigo epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT rodriguezvelasquezlucerojazmin epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT zapatacantonidia epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico
AT perezzunigajuanmanuel epidemiologyandclinicalcharacteristicsofnonhodgkinlymphomainmexico